JP2021506769A5 - - Google Patents

Download PDF

Info

Publication number
JP2021506769A5
JP2021506769A5 JP2020531748A JP2020531748A JP2021506769A5 JP 2021506769 A5 JP2021506769 A5 JP 2021506769A5 JP 2020531748 A JP2020531748 A JP 2020531748A JP 2020531748 A JP2020531748 A JP 2020531748A JP 2021506769 A5 JP2021506769 A5 JP 2021506769A5
Authority
JP
Japan
Prior art keywords
polypeptide
gram
lytic
fragment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020531748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021506769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/065265 external-priority patent/WO2019118632A1/en
Publication of JP2021506769A publication Critical patent/JP2021506769A/ja
Publication of JP2021506769A5 publication Critical patent/JP2021506769A5/ja
Priority to JP2023181425A priority Critical patent/JP7646237B2/ja
Pending legal-status Critical Current

Links

JP2020531748A 2017-12-12 2018-12-12 シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定 Pending JP2021506769A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023181425A JP7646237B2 (ja) 2017-12-12 2023-10-20 シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762597577P 2017-12-12 2017-12-12
US62/597,577 2017-12-12
US201862721969P 2018-08-23 2018-08-23
US62/721,969 2018-08-23
PCT/US2018/065265 WO2019118632A1 (en) 2017-12-12 2018-12-12 Identification of lysins and derivatives thereof with bacterial activity against pseudomonas aeruginosa

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023181425A Division JP7646237B2 (ja) 2017-12-12 2023-10-20 シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定

Publications (2)

Publication Number Publication Date
JP2021506769A JP2021506769A (ja) 2021-02-22
JP2021506769A5 true JP2021506769A5 (cg-RX-API-DMAC7.html) 2022-01-06

Family

ID=66819724

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020531748A Pending JP2021506769A (ja) 2017-12-12 2018-12-12 シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定
JP2023181425A Active JP7646237B2 (ja) 2017-12-12 2023-10-20 シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023181425A Active JP7646237B2 (ja) 2017-12-12 2023-10-20 シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定

Country Status (11)

Country Link
US (1) US12121568B2 (cg-RX-API-DMAC7.html)
EP (1) EP3723789A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021506769A (cg-RX-API-DMAC7.html)
KR (1) KR20200098615A (cg-RX-API-DMAC7.html)
CN (1) CN111971058A (cg-RX-API-DMAC7.html)
AU (1) AU2018384790C1 (cg-RX-API-DMAC7.html)
BR (1) BR112020011433A2 (cg-RX-API-DMAC7.html)
CA (1) CA3085644A1 (cg-RX-API-DMAC7.html)
IL (2) IL275060B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020006098A (cg-RX-API-DMAC7.html)
WO (1) WO2019118632A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020011433A2 (pt) 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
US20210062137A1 (en) * 2017-12-22 2021-03-04 The Rockefeller University Recombinant pseudomonas aeruginosa lysins
US10988520B2 (en) * 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
WO2019191633A2 (en) 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
EP3840771A4 (en) * 2018-08-23 2023-04-19 Contrafect Corporation POLYPEPTIDE CONSTRUCTS WITH LYSINE ANTIMICROBIAL PEPTIDE (AMP), LYSINE, ISOLATED POLYNUCLEOTIDES ENCODING THEREOF AND USES THEREOF
MX2021012166A (es) * 2019-04-05 2021-11-03 Contrafect Corp Lisinas y sus derivados con actividad bactericida contra pseudomona aeruginosa, en la presencia de suero humano.
KR102225240B1 (ko) * 2019-07-03 2021-03-10 경북대학교 산학협력단 다제내성 병원성 세균을 효과적으로 사멸시키는 재조합 항균 단백질 Ablysin의 용도
JP2023502940A (ja) * 2019-11-14 2023-01-26 コントラフェクト コーポレイション 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用
US20250324979A1 (en) * 2021-09-03 2025-10-23 Alexandre Ismail LysECD7 VARIANTS AND METHODS OF USING THE SAME
CN114410670B (zh) * 2022-01-29 2024-01-23 福建医科大学附属口腔医院 一种溶菌酶及其在口腔护理用品中的应用
CN117660413B (zh) * 2023-12-15 2024-06-07 华南理工大学 一种内溶素Lys009及其工程改造和应用
CN120173923B (zh) * 2025-05-08 2026-06-30 浙江大学 与PeiR裂解酶高维特征同源的产甲烷菌裂解酶及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
ES2761835T3 (es) 2009-02-06 2020-05-21 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Fagos antibacterianos, péptidos de fagos y métodos de uso de los mismos
WO2011060920A2 (en) * 2009-11-18 2011-05-26 Basf Plant Science Company Gmbh Process for the production of fine chemicals
DK2563916T3 (en) * 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
GB201018518D0 (en) 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
MX383544B (es) 2011-04-21 2025-03-14 Univ Rockefeller Lisinas de bacteriofago de streptococcus para la deteccion y tratamiento de bacterias gram positivas
WO2015070912A1 (en) 2013-11-14 2015-05-21 Lysando Ag Modified el188 endolysin sequence
BR112016030580B1 (pt) 2014-06-26 2023-12-19 The Rockefeller University Polipeptídeo de lisina e fragmento de polipeptídeo com atividade para matar bactérias gram-negativas
ES2934714T3 (es) 2015-09-17 2023-02-24 Contrafect Corp Polipéptidos de lisina activos contra bacterias Gram-negativas
BR112020011433A2 (pt) 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
CN108103050A (zh) 2018-02-11 2018-06-01 中国医药集团总公司四川抗菌素工业研究所 一种铜绿假单胞菌噬菌体裂解酶、其编码基因、重组表达载体及其制备方法和应用
WO2019191633A2 (en) 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
EP3840771A4 (en) 2018-08-23 2023-04-19 Contrafect Corporation POLYPEPTIDE CONSTRUCTS WITH LYSINE ANTIMICROBIAL PEPTIDE (AMP), LYSINE, ISOLATED POLYNUCLEOTIDES ENCODING THEREOF AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2021519083A5 (cg-RX-API-DMAC7.html)
IL277119B2 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP2024010053A5 (cg-RX-API-DMAC7.html)
RU2018107245A (ru) Полипептиды лизина, активные против грамотрицательных бактерий
Łusiak-Szelachowska et al. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far
JP2021533728A5 (cg-RX-API-DMAC7.html)
Shahrour et al. AMPs as anti-biofilm agents for human therapy and prophylaxis
IL313959A (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP2021519311A5 (cg-RX-API-DMAC7.html)
Simoes et al. Novel antibacterial agents: an emergent need to win the battle against infections
EP3164146B1 (en) Acinetobacter lysins
MX2020006098A (es) Lisinas y sus derivados con actividad bactericida contra pseudomona aeruginosa, en la presencia de suero humano.
CN112218659A (zh) 用于治疗葡萄球菌感染的治疗性噬菌体组合物
Zhang et al. In Vitro Study of Bacteriophage AB3 Endolysin LysAB3 Activity Against Acinetobacter baumannii Biofilm and Biofilm-Bound A. baumannii.
RU2020128276A (ru) МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
Ming et al. The antibacterial effects of antimicrobial peptides OP-145 against clinically isolated multi-resistant strains
Kozlovska et al. The effect of antimicrobial agents on planktonic and biofilm forms of bacteria that are isolated from chronic anal fissures
JP2021508501A (ja) Pseudomonas感染症を処置するためのバクテリオファージ組成物
JP2022526978A5 (cg-RX-API-DMAC7.html)
Borysowski et al. Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives
JP2023502940A5 (cg-RX-API-DMAC7.html)
RU2020131450A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий
Chowdhury et al. Synergy of antimicrobial peptides.
RU2021128336A (ru) Лизины и их производные с бактерицидной активностью против pseudomonas aeruginosa в присутствии сыворотки крови человека
Gadelii et al. Sensitizing agents to restore antibiotic resistance